Cardiometabolic diseases remain the leading cause of disability and mortality worldwide. Research has so far been primarily focused on middle-aged and older adults, Caucasian populations, and developed countries. However, cardiometabolic health has been worsening in children and young adults. The prevalence of cardiometabolic diseases has been increasing sharply in developing countries. Cardiometabolic disease risk is increased among certain minority groups and economically disadvantaged populations. Several periods such as pregnancy, emerging adulthood, and adolescence need special considerations. Nonetheless, high-quality data for guiding and promoting better cardiometabolic health in the aforementioned populations and periods are limited, which brings significant challenges for reducing the global burden of cardiometabolic diseases. This warrants advancing our understanding of the etiology, prevention, treatment, and management of cardiometabolic diseases in understudied but vulnerable populations and during critical periods. Multidisciplinary approaches and novel technologies will be important and encouraged. Tailored interventions are urgently needed.
Observational and interventional studies on human participants addressing the etiology, prevention, treatment, and management of cardiometabolic diseases are welcome. Cardiometabolic diseases of interest broadly include, but are not limited to:
· Obesity
· Diabetes
· Hypertension
· Dyslipidemia
· Cardiovascular disease
· Chronic kidney disease
The study populations of interest include, but are not limited to:
· Children and adolescents
· Young adults
· Women
· Populations of non-Caucasian backgrounds
· Populations from developing countries
· Economically disadvantaged populations
Cardiometabolic diseases remain the leading cause of disability and mortality worldwide. Research has so far been primarily focused on middle-aged and older adults, Caucasian populations, and developed countries. However, cardiometabolic health has been worsening in children and young adults. The prevalence of cardiometabolic diseases has been increasing sharply in developing countries. Cardiometabolic disease risk is increased among certain minority groups and economically disadvantaged populations. Several periods such as pregnancy, emerging adulthood, and adolescence need special considerations. Nonetheless, high-quality data for guiding and promoting better cardiometabolic health in the aforementioned populations and periods are limited, which brings significant challenges for reducing the global burden of cardiometabolic diseases. This warrants advancing our understanding of the etiology, prevention, treatment, and management of cardiometabolic diseases in understudied but vulnerable populations and during critical periods. Multidisciplinary approaches and novel technologies will be important and encouraged. Tailored interventions are urgently needed.
Observational and interventional studies on human participants addressing the etiology, prevention, treatment, and management of cardiometabolic diseases are welcome. Cardiometabolic diseases of interest broadly include, but are not limited to:
· Obesity
· Diabetes
· Hypertension
· Dyslipidemia
· Cardiovascular disease
· Chronic kidney disease
The study populations of interest include, but are not limited to:
· Children and adolescents
· Young adults
· Women
· Populations of non-Caucasian backgrounds
· Populations from developing countries
· Economically disadvantaged populations
